Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
or

Biogen Inc (BIIB)

Biogen Inc (BIIB)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
118.89 +2.40 (+2.06%) 04/22/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 119.90 +1.01 (+0.85%) 19:56 ET
Quote Overview for Tue, Apr 22nd, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
117.40
Day High
119.71
Open 118.12
Previous Close 116.49 116.49
Volume 1,076,700 1,076,700
Avg Vol 1,791,960 1,791,960
Stochastic %K 30.41% 30.41%
Weighted Alpha -47.13 -47.13
5-Day Change -0.37 (-0.31%) -0.37 (-0.31%)
52-Week Range 110.04 - 238.00 110.04 - 238.00
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 17,051,224
  • Shares Outstanding, K 146,375
  • Annual Sales, $ 9,676 M
  • Annual Income, $ 1,632 M
  • EBIT $ 2,696 M
  • EBITDA $ 3,660 M
  • 60-Month Beta 0.06
  • Price/Sales 1.79
  • Price/Cash Flow 5.13
  • Price/Book 1.03

Options Overview Details

View History
  • Implied Volatility 46.02% ( -2.06%)
  • Historical Volatility 42.59%
  • IV Percentile 96%
  • IV Rank 56.69%
  • IV High 64.86% on 04/09/25
  • IV Low 21.36% on 09/10/24
  • Put/Call Vol Ratio 0.90
  • Today's Volume 1,679
  • Volume Avg (30-Day) 3,240
  • Put/Call OI Ratio 0.91
  • Today's Open Interest 83,813
  • Open Int (30-Day) 87,272

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 33 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate 3.34
  • Number of Estimates 24
  • High Estimate 4.03
  • Low Estimate 1.94
  • Prior Year 3.67
  • Growth Rate Est. (year over year) -8.99%

Price Performance

See More
Period Period Low Period High Performance
1-Month
110.04 +8.04%
on 04/09/25
Period Open: 140.90
144.15 -17.52%
on 03/24/25
-22.01 (-15.62%)
since 03/21/25
3-Month
110.04 +8.04%
on 04/09/25
Period Open: 142.75
157.09 -24.32%
on 03/10/25
-23.86 (-16.71%)
since 01/22/25
52-Week
110.04 +8.04%
on 04/09/25
Period Open: 194.11
238.00 -50.05%
on 07/12/24
-75.22 (-38.75%)
since 04/22/24

Most Recent Stories

More News
Earnings Preview: What To Expect From Biogen's Report

Biogen is poised to announce its first-quarter results next month, and analysts predict a single-digit dip in the company’s bottom-line figure.

XLV : 135.06 (+1.88%)
$SPX : 5,287.76 (+2.51%)
BIIB : 118.89 (+2.06%)
European regulators OK Alzheimer's treatment Leqembi after initial doubts

European regulators have finally approved the Alzheimer’s treatment Leqembi after an advisory committee initially rejected the drug last summer

BIIB : 118.89 (+2.06%)
Leqembi®∇ (lecanemab) is the First Medicine that Slows Progression of Early Alzheimer’s Disease to be Authorized in the European Union

BIIB : 118.89 (+2.06%)
Stocks Spike as Trump Announces 90-Day Tariff Pause

The S&P 500 Index ($SPX ) (SPY ) today is up +5.99%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +3.96%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +7.05%. June E-mini S&P futures (ESM25...

ALK : 44.94 (+2.88%)
GOOGL : 151.47 (+2.57%)
MPC : 131.39 (+3.69%)
AAPL : 199.74 (+3.41%)
JNJ : 157.75 (+0.53%)
AMGN : 278.40 (+1.72%)
PFE : 22.53 (+2.22%)
OXY : 39.97 (+2.43%)
TSLA : 237.97 (+4.60%)
FANG : 136.54 (+3.17%)
AMD : 86.26 (+0.82%)
SPY : 527.25 (+2.60%)
Stocks Supported by Strength in Megacap Technology and Airline Stocks

The S&P 500 Index ($SPX ) (SPY ) today is up +0.64%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.29%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +1.49%. June E-mini S&P futures (ESM25...

ALK : 44.94 (+2.88%)
GOOGL : 151.47 (+2.57%)
MPC : 131.39 (+3.69%)
AAPL : 199.74 (+3.41%)
ADI : 178.50 (+2.01%)
JNJ : 157.75 (+0.53%)
AMGN : 278.40 (+1.72%)
PFE : 22.53 (+2.22%)
OXY : 39.97 (+2.43%)
TSLA : 237.97 (+4.60%)
FANG : 136.54 (+3.17%)
AMD : 86.26 (+0.82%)
Spotting Winners: United Therapeutics (NASDAQ:UTHR) And Therapeutics Stocks In Q4

Spotting Winners: United Therapeutics (NASDAQ:UTHR) And Therapeutics Stocks In Q4

BMRN : 61.50 (+4.86%)
VRTX : 490.47 (+2.71%)
MRNA : 25.74 (+2.43%)
UTHR : 292.82 (+3.01%)
BIIB : 118.89 (+2.06%)
Biogen’s Investigational Tau-Targeting Therapy BIIB080 Receives FDA Fast Track Designation for the Treatment of Alzheimer’s Disease

BIIB : 118.89 (+2.06%)
Stocks Finish Higher as Magnificent Seven Stocks Rally

The S&P 500 Index ($SPX ) (SPY ) Tuesday closed up +0.38%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.03%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.82%. June E-mini S&P...

ALK : 44.94 (+2.88%)
GOOGL : 151.47 (+2.57%)
UAL : 66.97 (+2.56%)
AAPL : 199.74 (+3.41%)
PVH : 71.66 (+3.26%)
ADI : 178.50 (+2.01%)
JNJ : 157.75 (+0.53%)
MRK : 78.97 (+1.44%)
TXN : 146.76 (+0.79%)
$IUXX : 18,276.41 (+2.63%)
PFE : 22.53 (+2.22%)
ZNM25 : 110-285 (+0.08%)
Analysts Love These 2 Growth Stocks That Have Over 200% Upside Potential

Wall Street expects both of these biotech stocks to soar over 200% in the next 12 months.

AKBA : 2.14 (+3.38%)
STOK : 9.22 (+7.08%)
ACAD : 14.35 (-0.21%)
BIIB : 118.89 (+2.06%)
Beyond GLP-1 Drugs: This Opportunity at Eli Lilly Could Surprise Everyone in 2025

Mounjaro and Zepbound are Eli Lilly's largest sources of growth, but there is much more to the company.

LLY : 827.54 (+1.16%)
BIIB : 118.89 (+2.06%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Biogen Inc. is one of the world's leading biotechnology companies which focuses on developing innovative therapies for treating serious neurological and neurodegenerative diseases, including its core growth areas of multiple sclerosis (MS) and neuroimmunology, Alzheimer's disease (AD) and dementia, movement...

See More

Key Turning Points

3rd Resistance Point 122.24
2nd Resistance Point 120.98
1st Resistance Point 119.93
Last Price 118.89
1st Support Level 117.62
2nd Support Level 116.36
3rd Support Level 115.31

See More

52-Week High 238.00
Fibonacci 61.8% 189.12
Fibonacci 50% 174.02
Fibonacci 38.2% 158.92
Last Price 118.89
52-Week Low 110.04

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Unlock High-Probability Trade Setups: Master Fractals & Time Frames Like a Pro